P75NTR+CD64+ neutrophils promote sepsis-induced acute lung injury. 2024

Di Fu, and Shan Gao, and Jia-Nan Li, and Yan-Hui Cui, and Yan-Wei Luo, and Yan-Jun Zhong, and Qiao Li, and Cong Luo, and Ru-Ping Dai, and Ru-Yi Luo, and Zhao-Lan Hu
Department of Anesthesiology, The Xiangya Hospital, Central South University, Changsha City, Hunan 410008, China.

Patients suffering from sepsis-induced acute lung injury (ALI) exhibit a high mortality rate, and their prognosis is closely associated with infiltration of neutrophils into the lungs. In this study, we found a significant elevation of CD64+ neutrophils, which highly expressed p75 neurotrophin receptor (p75NTR) in peripheral blood of mice and patients with sepsis-induced ALI. p75NTR+CD64+ neutrophils were also abundantly expressed in the lung of ALI mice induced by lipopolysaccharide. Conditional knock-out of the myeloid lineage's p75NTR gene improved the survival rates, attenuated lung tissue inflammation, reduced neutrophil infiltration and enhanced the phagocytic functions of CD64+ neutrophils. In vitro, p75NTR+CD64+ neutrophils exhibited an upregulation and compromised phagocytic activity in blood samples of ALI patients. Blocking p75NTR activity by soluble p75NTR extracellular domain peptide (p75ECD-Fc) boosted CD64+ neutrophils phagocytic activity and reduced inflammatory cytokine production via regulation of the NF-κB activity. The findings strongly indicate that p75NTR+CD64+ neutrophils are a novel pathogenic neutrophil subpopulation promoting sepsis-induced ALI.

UI MeSH Term Description Entries

Related Publications

Di Fu, and Shan Gao, and Jia-Nan Li, and Yan-Hui Cui, and Yan-Wei Luo, and Yan-Jun Zhong, and Qiao Li, and Cong Luo, and Ru-Ping Dai, and Ru-Yi Luo, and Zhao-Lan Hu
March 2019, The European respiratory journal,
Di Fu, and Shan Gao, and Jia-Nan Li, and Yan-Hui Cui, and Yan-Wei Luo, and Yan-Jun Zhong, and Qiao Li, and Cong Luo, and Ru-Ping Dai, and Ru-Yi Luo, and Zhao-Lan Hu
October 2001, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society,
Di Fu, and Shan Gao, and Jia-Nan Li, and Yan-Hui Cui, and Yan-Wei Luo, and Yan-Jun Zhong, and Qiao Li, and Cong Luo, and Ru-Ping Dai, and Ru-Yi Luo, and Zhao-Lan Hu
April 2019, Annals of translational medicine,
Di Fu, and Shan Gao, and Jia-Nan Li, and Yan-Hui Cui, and Yan-Wei Luo, and Yan-Jun Zhong, and Qiao Li, and Cong Luo, and Ru-Ping Dai, and Ru-Yi Luo, and Zhao-Lan Hu
October 2023, International immunopharmacology,
Di Fu, and Shan Gao, and Jia-Nan Li, and Yan-Hui Cui, and Yan-Wei Luo, and Yan-Jun Zhong, and Qiao Li, and Cong Luo, and Ru-Ping Dai, and Ru-Yi Luo, and Zhao-Lan Hu
January 2021, Blood,
Di Fu, and Shan Gao, and Jia-Nan Li, and Yan-Hui Cui, and Yan-Wei Luo, and Yan-Jun Zhong, and Qiao Li, and Cong Luo, and Ru-Ping Dai, and Ru-Yi Luo, and Zhao-Lan Hu
January 2021, Frontiers in microbiology,
Di Fu, and Shan Gao, and Jia-Nan Li, and Yan-Hui Cui, and Yan-Wei Luo, and Yan-Jun Zhong, and Qiao Li, and Cong Luo, and Ru-Ping Dai, and Ru-Yi Luo, and Zhao-Lan Hu
January 2009, Critical care (London, England),
Di Fu, and Shan Gao, and Jia-Nan Li, and Yan-Hui Cui, and Yan-Wei Luo, and Yan-Jun Zhong, and Qiao Li, and Cong Luo, and Ru-Ping Dai, and Ru-Yi Luo, and Zhao-Lan Hu
December 2018, Journal of leukocyte biology,
Di Fu, and Shan Gao, and Jia-Nan Li, and Yan-Hui Cui, and Yan-Wei Luo, and Yan-Jun Zhong, and Qiao Li, and Cong Luo, and Ru-Ping Dai, and Ru-Yi Luo, and Zhao-Lan Hu
September 2023, American journal of physiology. Lung cellular and molecular physiology,
Di Fu, and Shan Gao, and Jia-Nan Li, and Yan-Hui Cui, and Yan-Wei Luo, and Yan-Jun Zhong, and Qiao Li, and Cong Luo, and Ru-Ping Dai, and Ru-Yi Luo, and Zhao-Lan Hu
September 2020, Chinese medical journal,
Copied contents to your clipboard!